Haftka joins Metabolix, ADM's European Telles venture

Metabolix Inc. and Archer Daniels Midland Co. appointed Stan Haftka as director of business development, Europe, for Telles, the joint venture that is commercializing Mirel bioplastics. Haftka will lead European business development with the opening of Telles' first international office at ADM's Europoort facility in the Netherlands. Haftka has 20 years of experience in the global specialty polymer market and brings leadership assets important for the organization's international growth. Haftka joins Telles from the engineering polymers business of Celanese Corp., where he was responsible for managing the business segment globally. He successfully developed and implemented new business strategies, managed numerous product and application platforms, and received patents for new polymer applications.